A study to improve the quality of life among people with non-communicable diseases in Bolivia and Guatemala using DIALOG+

A hybrid type I effectiveness-implementation trial of DIALOG+ to improve quality of life among people with non-communicable diseases (diabetes, hypertension and obesity) and mental health conditions (anxiety, depression and alcohol consumption) in Bolivia and Guatemala

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN41577200

Enrollment

230

Registered

2026-01-26

Start date

2026-03-23

Completion date

Unknown

Last updated

2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-communicable diseases: diabetes, hypertension, obesity

Interventions

Healthcare professionals from selected health centers will be recruited, and their cases will be assessed to identify patients who may meet the inclusion criteria. The randomization unit will be the g

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Men and women aged 18 to 75 years 2. Understanding of Spanish (speaking and reading) 3. Have a residency in the country in which they were recruited 4. Report a low quality of life based on MANSA test score =5 5. A diagnosis of a physical NCD (diabetes, hypertension and obesity) 6. A diagnosis or a positive screening for at least one mental health condition (anxiety, depression and alcohol consumption)

Exclusion criteria

Exclusion criteria: 1. Diagnosis of dementia or cognitive impairment 2. Clinical diagnosis of schizophrenia or other psychotic disorders 3. Being hospitalized at the time of recruitment, irrespective of the cause

Countries

Bolivia, Guatemala

Contacts

Public ContactEdgar Miguel;Ronald Fernando López Álvarez;Tapia Pijuan

;

emlopeza@url.edu.gt;ronaldfernandotp@hotmail.com+502 (0)40173026;+591 (0)78510007

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 3, 2026